Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: JW Holdings Corporation
Street 1: 2477 Nambusunhwan-ro, Seocho-gu, Seoul 137-864
Street 2:
City: Seoul
Province:
Post Code: 137-864
Country: Republic of Korea
Phone: 82-2-840-6774
Email: jimmy777@jw-holdings.co.kr
Web Site: http://www.jw-holdings.co.kr

Focal Point Contact Information

Salutation: Mr
First Name: Beom Chan
Last Name: Lee
Title: Senior manager
Email: bclee@jw-holdings.co.kr
Phone: 82-2-840-6775

Alternate Focal Point Contact Information

Salutation: NA
First Name: NA
Last Name: NA
Title: NA
Email: NA
Phone: NA

General Information

Board Constituency: Private sector
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
JW Group, which was established in 1945 in Korea based on its founding ideas of respect for life and the pioneering spirit. JW has led a Korean hospital market by a number of critical care products and is reinforcing its global competitive edge. It is also putting all its efforts into developing new,innovative drugs through a global R&D network.
JW is exporting some competitive products to developing markets at the most competitive price so that more patients can afford to high quality products.
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 100 +
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? Unable to disclose amount
How did you hear about the Stop TB Partnership: Other partners
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Information on developments within the TB world
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
We are looking for an opportunity to supply our high quality products at a competitive price.
 

Geographical Reach

Which country is your headquarters located in: Republic of Korea
Which WHO region is the main focus of your work: Western Pacific
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Republic of Korea

Specializations

Provision of drugs, diagnostics and commodities

Specializations in Countries

Provision of drugs, diagnostics and commodities Republic of Korea

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

New TB Drugs:
Imipenem+Cilastatin inj. is newly listed on the purchase forecast and JW is willing to supply it.

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: February 5, 2015
Last updated: October 22, 2015